Business Description

Syneos Health Inc
NAICS : 541714
SIC : 8731
ISIN : US87166B1026
Share Class Description:
SYNH: Class ADescription
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.83 | |||||
Debt-to-EBITDA | 6.57 | |||||
Interest Coverage | 3.03 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.4 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.4 | |||||
3-Year EBITDA Growth Rate | 11.3 | |||||
3-Year EPS without NRI Growth Rate | 23.1 | |||||
3-Year FCF Growth Rate | 10 | |||||
3-Year Book Growth Rate | 5.2 | |||||
Future 3-5Y EPS without NRI Growth Rate | 1.27 | |||||
Future 3-5Y Total Revenue Growth Rate | 0.75 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 83.45 | |||||
9-Day RSI | 76.94 | |||||
14-Day RSI | 72.61 | |||||
6-1 Month Momentum % | 22.22 | |||||
12-1 Month Momentum % | -10.07 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.2 | |||||
Quick Ratio | 1.2 | |||||
Cash Ratio | 0.05 | |||||
Days Sales Outstanding | 60.51 | |||||
Days Payable | 10.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | 5 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 22.14 | |||||
Operating Margin % | 6.33 | |||||
Net Margin % | 1.31 | |||||
FCF Margin % | 2.99 | |||||
ROE % | 2.08 | |||||
ROA % | 0.87 | |||||
ROIC % | 4.02 | |||||
ROC (Joel Greenblatt) % | 48.83 | |||||
ROCE % | 3.03 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 62.29 | |||||
Forward PE Ratio | 11.51 | |||||
PE Ratio without NRI | 19.33 | |||||
Shiller PE Ratio | 39.83 | |||||
Price-to-Owner-Earnings | 44.96 | |||||
PEG Ratio | 0.83 | |||||
PS Ratio | 0.82 | |||||
PB Ratio | 1.28 | |||||
Price-to-Free-Cash-Flow | 27.31 | |||||
Price-to-Operating-Cash-Flow | 17.51 | |||||
EV-to-EBIT | 37.08 | |||||
EV-to-Forward-EBIT | 13.28 | |||||
EV-to-EBITDA | 16.5 | |||||
EV-to-Forward-EBITDA | 10.04 | |||||
EV-to-Revenue | 1.34 | |||||
EV-to-Forward-Revenue | 1.38 | |||||
EV-to-FCF | 44.91 | |||||
Price-to-Projected-FCF | 0.82 | |||||
Price-to-DCF (Earnings Based) | 0.62 | |||||
Price-to-DCF (FCF Based) | 0.93 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.85 | |||||
Earnings Yield (Greenblatt) % | 2.7 | |||||
FCF Yield % | 3.63 | |||||
Forward Rate of Return (Yacktman) % | 17.33 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SYNH
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Syneos Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 5,418.97 | ||
EPS (TTM) ($) | 0.69 | ||
Beta | 0 | ||
Volatility % | 44.33 | ||
14-Day RSI | 72.61 | ||
14-Day ATR ($) | 0.105836 | ||
20-Day SMA ($) | 42.7995 | ||
12-1 Month Momentum % | -10.07 | ||
52-Week Range ($) | 22.8941 - 52.23 | ||
Shares Outstanding (Mil) | 103.72 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Syneos Health Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Syneos Health Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Syneos Health Inc Frequently Asked Questions
What is Syneos Health Inc(SYNH)'s stock price today?
The current price of SYNH is $42.98. The 52 week high of SYNH is $52.23 and 52 week low is $22.89.
When is next earnings date of Syneos Health Inc(SYNH)?
The next earnings date of Syneos Health Inc(SYNH) is 2024-02-16 Est..
Does Syneos Health Inc(SYNH) pay dividends? If so, how much?
Syneos Health Inc(SYNH) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |